European Medicines Agency
See the following -
CDISC and TransCelerate Announce New Standard for Breast Cancer to Support Data Sharing for Oncology Research
The need to rapidly and efficiently share new data in cancer research was recently, and powerfully, highlighted by U.S. Vice President Joe Biden as part of the Cancer Moonshot initiative. The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma, Inc. (“TransCelerate”) announce today the open availability of a new CDISC Therapeutic Area (TA) Standard for Breast Cancer. The CDISC global TA standards can streamline the way clinical research is conducted so that data can be readily shared among clinicians, researchers and regulators around the world, thus leading to more rapid and “smarter” research...
- Login to post comments
New Arms Race: Science Versus Antibiotic-Resistant Superbugs
The death rate from bacterial infections plummeted following the discovery of penicillin. However, these microbes developed ways to resist our antibiotics. What threats do superbugs pose and what factors contribute to their emergence? The discovery and development of antibiotics saved millions of lives during the latter half of the 20th century. Scottish bacteriologist Alexander Fleming, who witnessed soldiers with infected wounds perish while serving in the Royal Army Medical Corps during the First World War, per chance discovered a penicillin producing mold in 1928...
- Login to post comments